Company Data

Astria Therapeutics Inc.

Ticker
ATXS
Current Price
$6.81 -0.15%
Market Cap
$384.3M
Price Target
Refer to Report
Volume
206.9K
52wk Range
$6.64 - $16.9
Advanced Market Data

Overview

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy